Gynesonics is a leading brand dedicated to advancing women's health through the development of innovative technologies. With a focus on transcervical, uterus-preserving, incisionless solutions, Gynesonics offers diagnostic and therapeutic applications for various gynecological conditions. The company is committed to providing women with a safe and effective alternative to invasive surgical techniques like hysterectomy or myomectomy for symptomatic uterine fibroids.

At Gynesonics, their mission is to improve the lives of women by offering groundbreaking solutions that are minimally invasive and preserve fertility. Their flagship product, the Sonata System, is designed to revolutionize the treatment of uterine fibroids and offers a nonsurgical, outpatient procedure. Backed by a dedicated management team and a board of directors, Gynesonics is constantly pushing the boundaries of medical technology to ensure the highest standards of care for women worldwide.

With a strong emphasis on compliance, quality, and patient safety, Gynesonics has established itself as a trusted name in women's health